Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in Peri-surgical Tube Otorrhea
2018-000642-19Phase 2
- Sponsor
- Alcon Inc.
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of moxidex in acute otitis media (AOM) and otitis media, sponsored by Alcon Inc. Primary endpoint: Time to Cessation of Otorrhea.
02
Drugs
moxidex
03
Conditions
acute otitis media (AOM)otitis media
Beyond the preview
Go deeper on 2018-000642-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000642-19.